Answers are grounded in this paper and cite their sources.
Review explores immune responses and resistance in Streptococcus pneumoniae, suggesting novel therapeutic strategies.
Streptococcus pneumoniae is a significant human pathogen that causes numerous diseases worldwide, posing challenges due to its antibiotic resistance. Understanding its immunological characteristics is crucial for the development of vaccines and effective treatment strategies. This review explores innate and adaptive immune responses against S. pneumoniae and highlights differences between antibiotic-resistant and susceptible strains. Innate responses involve Toll-like receptors (TLR), macrophages, neutrophils, dendritic cells, activating pro-inflammatory cytokines, and phagocytosis. Adaptive responses, led by T helper cells, produce cytokines like interferon-gamma (Th1) and interleukin-17 (Th17), crucial for pathogen clearance. Antibody production by B cells supports opsonization and neutralization. However, antibiotic resistance alters surface proteins, influences immune recognition, and accelerates inflammation. As a result, infections by resistant strains create challenges in treatment effectiveness and immune response, which involve in novel strategies. Future prospective involve broad-spectrum vaccines targeting diverse serotypes, novel antibiotics, combination therapies, immunotherapies, and host-directed treatments. Supervision and understanding of immune evasion mechanisms are much required. Collaboration and research investment are fundamental in combating S. pneumoniae infections effectively, improving clinical outcomes, and protecting vulnerable populations.
No takes yet. Share an insight, caveat, or question.
Jana et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: